Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miriam Valenzuela-Cardenas
Observed names:
Miriam B. Valenzuela-Cardenas,
Miriam Valenzuela Cardenas
Institutions:
University of California, Los Angeles,
University of New Mexico,
University of New Mexico Health Sciences Center
Observed institutions:
University of California, Los Angeles,
University of New Mexico,
University of New Mexico Health Sciences Center
ORCID:
0009-0005-0314-4952
Observed ORCID:
0009-0005-0314-4952
OpenAlex ID:
A5039994676
TNF-alpha: Roles in pathogenesis and therapeutics in cancer
2026
·
Miriam Valenzuela Cardenas
, Theodore Scott Nowicki
·
Journal of Biological Chemistry
·
18
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy
2022
·
Miriam Valenzuela-Cardenas
, Cody Gowan
, et al.
·
Journal for ImmunoTherapy of Cancer
·
13
PDF
Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection
2023
·
Raquela J. Thomas
, Mee Y. Bartee
, et al.
·
Molecular Therapy — Oncolytics
·
8
IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade
2024
·
Miriam Valenzuela-Cardenas
, Carrie Fisher
, et al.
·
Molecular Therapy Oncology
·
5
Microbe Snapshot: Corynebacterium diphtheriae
2025
·
Miriam B. Valenzuela-Cardenas
, Samuel M. Goodfellow
·
Clinical Microbiology Newsletter
·
1
Novel Synthetic Promoter Armed Oncolytic Herpes Simplex Virus For Treatment of PAX3-FOXO1 Positive Rhabdomyosarcoma
2026
·
Cole Peters
, Miriam Valenzuela Cardenas
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 5616: Tumor necrosis factor-alpha armed TCR-T and CAR-T cells for solid tumors provide superior anticancer activity in the absence of toxicity
2026
·
Cole W. Peters
, Miriam Valenzuela Cardenas
, et al.
·
Cancer Research
Abstract 1569: Treatment of PAX3-FOXO1 alveolar rhabdomyosarcoma with ICP34.5-armed G47Δ oncolytic herpes simplex virus confers survival benefit when co-administered with anti-Pd1 antibody
2026
·
Cole W. Peters
, Miriam Valenzuela-Cardenas
, et al.
·
Cancer Research
Interleukin-7R and chemokine receptor type 7 differentially regulate metabolism in CD4+ and CD8+ T cells
2026
·
Kimberly A Morrissey
, Miriam Valenzuela-Cardenas
, et al.
·
ImmunoHorizons
Metabolic Drivers of T Cell Migration: Distinct Roles of CCL21 and IL-7 in ATP Production and Motility 3199
2025
·
Kimberly A. Morrissey
, Rebekah Gridley
, et al.
·
The Journal of Immunology
PDF
Show more works
View as search
Works count:
10
Citation count:
45
H-index:
4
I10-index:
2
Year
Topic
Type
